427 related articles for article (PubMed ID: 8554529)
1. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
Elass-Rochard E; Roseanu A; Legrand D; Trif M; Salmon V; Motas C; Montreuil J; Spik G
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.
Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):841-6. PubMed ID: 9581564
[TBL] [Abstract][Full Text] [Related]
3. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis.
van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
Eur J Biochem; 2004 Feb; 271(4):678-84. PubMed ID: 14764083
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.
Elass-Rochard E; Legrand D; Salmon V; Roseanu A; Trif M; Tobias PS; Mazurier J; Spik G
Infect Immun; 1998 Feb; 66(2):486-91. PubMed ID: 9453600
[TBL] [Abstract][Full Text] [Related]
5. Characterization of monoclonal antibodies against human lactoferrin.
van Berkel PH; van Veen HA; Geerts ME; Nuijens JH
J Immunol Methods; 2002 Sep; 267(2):139-50. PubMed ID: 12165435
[TBL] [Abstract][Full Text] [Related]
6. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis.
van Berkel PH; Geerts ME; van Veen HA; Kooiman PM; Pieper FR; de Boer HA; Nuijens JH
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):107-14. PubMed ID: 7492299
[TBL] [Abstract][Full Text] [Related]
7. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.
Håversen LA; Engberg I; Baltzer L; Dolphin G; Hanson LA; Mattsby-Baltzer I
Infect Immun; 2000 Oct; 68(10):5816-23. PubMed ID: 10992490
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections.
Naidu SS; Erdei J; Czirók E; Kalfas S; Gadó I; Thorén A; Forsgren A; Naidu AS
APMIS; 1991 Dec; 99(12):1142-50. PubMed ID: 1772651
[TBL] [Abstract][Full Text] [Related]
9. The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus.
El Yazidi-Belkoura I; Legrand D; Nuijens J; Slomianny MC; van Berkel P; Spik G
Biochim Biophys Acta; 2001 Dec; 1568(3):197-204. PubMed ID: 11786226
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin-binding proteins in Shigella flexneri.
Tigyi Z; Kishore AR; Maeland JA; Forsgren A; Naidu AS
Infect Immun; 1992 Jul; 60(7):2619-26. PubMed ID: 1319403
[TBL] [Abstract][Full Text] [Related]
11. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.
van Berkel PH; Geerts ME; van Veen HA; Mericskay M; de Boer HA; Nuijens JH
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):145-51. PubMed ID: 9359845
[TBL] [Abstract][Full Text] [Related]
12. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex.
Baveye S; Elass E; Fernig DG; Blanquart C; Mazurier J; Legrand D
Infect Immun; 2000 Dec; 68(12):6519-25. PubMed ID: 11083760
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of bovine lactoferrin as a glycyrrhizin-binding protein in vitro.
Tanigawa K; Fujihara M; Furuya T; Shimoyama Y; Morishima N; Ohtsuki K
Biol Pharm Bull; 2000 Apr; 23(4):438-42. PubMed ID: 10784423
[TBL] [Abstract][Full Text] [Related]
14. Role of the first N-terminal basic cluster of human lactoferrin (R2R3R4R5) in the interactions with the Jurkat human lymphoblastic T-cells.
Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
Adv Exp Med Biol; 1998; 443():49-55. PubMed ID: 9781342
[TBL] [Abstract][Full Text] [Related]
15. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells.
Roy MK; Kuwabara Y; Hara K; Watanabe Y; Tamai Y
J Dairy Sci; 2002 Sep; 85(9):2065-74. PubMed ID: 12362437
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human intelectin binds bovine lactoferrin and its peptides.
Shin K; Wakabayashi H; Yamauchi K; Yaeshima T; Iwatsuki K
Biol Pharm Bull; 2008 Aug; 31(8):1605-8. PubMed ID: 18670097
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a bovine lactoferrin binding protein of Streptococcus uberis.
Moshynskyy I; Jiang M; Fontaine MC; Perez-Casal J; Babiuk LA; Potter AA
Microb Pathog; 2003 Nov; 35(5):203-15. PubMed ID: 14521879
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution.
Moore SA; Anderson BF; Groom CR; Haridas M; Baker EN
J Mol Biol; 1997 Nov; 274(2):222-36. PubMed ID: 9398529
[TBL] [Abstract][Full Text] [Related]
19. Analytical cation-exchange chromatography to assess the identity, purity, and N-terminal integrity of human lactoferrin.
van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
Anal Biochem; 2002 Oct; 309(1):60-6. PubMed ID: 12381362
[TBL] [Abstract][Full Text] [Related]
20. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
